Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 14 04:00PM ET
7.96
Dollar change
-0.23
Percentage change
-2.81
%
IndexRUT P/E- EPS (ttm)-2.71 Insider Own33.51% Shs Outstand26.65M Perf Week-6.57%
Market Cap263.16M Forward P/E- EPS next Y-2.93 Insider Trans-0.67% Shs Float21.98M Perf Month-17.68%
Income-77.22M PEG- EPS next Q-0.69 Inst Own66.07% Short Float9.43% Perf Quarter-37.03%
Sales0.00M P/S- EPS this Y77.51% Inst Trans14.19% Short Ratio6.10 Perf Half Y-34.16%
Book/sh4.99 P/B1.59 EPS next Y-4.96% ROA-60.10% Short Interest2.07M Perf Year-
Cash/sh5.29 P/C1.50 EPS next 5Y- ROE-74.84% 52W Range7.86 - 22.33 Perf YTD-40.69%
Dividend Est.- P/FCF- EPS past 5Y- ROI-44.60% 52W High-64.35% Beta-
Dividend TTM- Quick Ratio9.38 Sales past 5Y19.69% Gross Margin- 52W Low1.27% ATR (14)0.60
Dividend Ex-Date- Current Ratio9.38 EPS Y/Y TTM- Oper. Margin0.00% RSI (14)32.81 Volatility5.15% 6.87%
Employees58 Debt/Eq0.07 Sales Y/Y TTM- Profit Margin- Recom1.17 Target Price22.83
Option/ShortNo / Yes LT Debt/Eq0.05 EPS Q/Q-27.58% Payout- Rel Volume0.67 Prev Close8.19
Sales Surprise- EPS Surprise7.43% Sales Q/Q- EarningsAug 12 BMO Avg Volume339.88K Price7.96
SMA20-11.43% SMA50-23.75% SMA200-42.01% Trades Volume226,510 Change-2.81%
Date Action Analyst Rating Change Price Target Change
Jun-13-24Initiated Robert W. Baird Outperform $28
Jun-06-24Initiated H.C. Wainwright Buy $22
Nov-28-23Initiated Stifel Buy $20
Nov-28-23Initiated RBC Capital Mkts Outperform $22
Nov-28-23Initiated Leerink Partners Outperform $19
Nov-28-23Initiated JP Morgan Overweight $20
Nov-28-23Initiated Chardan Capital Markets Buy $23
Sep-05-24 07:30AM
Aug-12-24 07:00AM
Jul-16-24 11:03AM
Jul-15-24 04:17PM
10:11AM
06:36AM Loading…
06:36AM
06:00AM
Jul-11-24 08:00AM
Jul-08-24 07:00AM
May-14-24 12:00PM
09:55AM
May-09-24 07:00AM
May-07-24 07:30AM
Apr-22-24 07:30AM
Apr-16-24 07:30AM
04:22PM Loading…
Mar-13-24 04:22PM
Mar-11-24 07:42AM
07:30AM
Feb-05-24 07:00AM
Jan-03-24 07:00AM
Dec-18-23 07:00AM
Dec-13-23 04:59AM
Dec-11-23 12:05PM
07:00AM
Nov-30-23 08:42AM
Nov-02-23 09:51PM
Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer's disease. It offers LX2006 for the treatment of patients with Friedreich's ataxia, cardiomyopathy, and LX1001 for APOE4 homozygous patients with Alzheimer's disease. The company was founded by Ronald G. Crystal in February 2017 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Townsend Richard NolanChief Executive OfficerSep 10 '24Option Exercise2.335,00011,650125,695Sep 11 05:17 PM
Townsend Richard NolanChief Executive OfficerSep 10 '24Sale10.655,00053,274120,695Sep 11 05:17 PM
Richard Nolan TownsendDirectorSep 10 '24Proposed Sale10.7912,500134,875Sep 10 04:39 PM
Townsend Richard NolanChief Executive OfficerAug 12 '24Option Exercise2.335,00011,650125,695Aug 13 06:34 PM
Townsend Richard NolanChief Executive OfficerAug 12 '24Sale11.535,00057,634120,695Aug 13 06:34 PM
Townsend Richard NolanChief Executive OfficerJul 10 '24Option Exercise2.335,00011,650175,695Jul 12 04:55 PM
Townsend Richard NolanChief Executive OfficerJul 11 '24Sale17.0728,031478,409120,695Jul 12 04:55 PM
Townsend Richard NolanChief Executive OfficerJul 10 '24Sale16.5026,969444,979148,726Jul 12 04:55 PM
Townsend Richard NolanChief Executive OfficerJun 10 '24Option Exercise2.335,00011,650175,695Jun 12 05:00 PM
Townsend Richard NolanChief Executive OfficerJun 10 '24Sale17.655,00088,264170,695Jun 12 05:00 PM
Townsend Richard NolanChief Executive OfficerMay 13 '24Option Exercise2.335,00011,650175,695May 14 04:04 PM
Townsend Richard NolanChief Executive OfficerMay 13 '24Sale13.225,00066,093170,695May 14 04:04 PM
Omega Fund VI, L.P.10% OwnerNov 07 '23Buy11.00454,5454,999,9952,157,623Nov 09 08:36 PM
Lundbeckfond Invest A/S10% OwnerNov 07 '23Buy11.00227,2722,499,9921,835,959Nov 09 08:33 PM
Longitude Capital Partners IV,10% OwnerNov 07 '23Buy11.00454,5454,999,9952,567,100Nov 09 08:32 PM